When budget stops being the main filter

This page is for you if

You have a workable budget and now need to compare routes by fit, not just affordability
You're comparing the UK, Portugal, Denmark, Spain, or Greece and want to see the trade-offs clearly
You want to know whether spending more buys a real structural advantage, or just a different set of trade-offs
You're over 50 and wondering whether a bigger budget changes your age-limit reality

What a higher budget actually changes

Above a basic threshold, all eight covered countries sit within reach. Budget stops being the first filter. The decision shifts to fit.

What it may change

What it does not change

Makes the UK more realistic as an identifiable-donor option

Donor law in anonymous-only countries (Spain, Czech Republic, North Cyprus, South Africa)

May widen clinic choice in established anonymous-donor markets like Spain

Age limits in any covered country

Confirms that cost is no longer the main obstacle to the decision

Single-women access rules or regulatory context

May create room for optional extras: broader package scope, PGT-A, expanded screening, or embryo storage

A higher quote does not mean those extras are necessary, evidence-based, or included as standard. What a package covers varies significantly by clinic and cycle type.

How your situation shapes what matters next

Once budget is no longer the constraint

If identifiable donation matters: Portugal and the UK are the two identifiable-only countries in the covered set. Denmark offers a choice between anonymous and identifiable. Portugal sits at €6,000–€9,000 base, the UK at €9,500–€13,500 base. A higher budget does not create identifiable donors in anonymous-only countries.
If you are over 50: budget matters less than age access here. Greece accepts patients to 54 and North Cyprus to around 58. Both typically sit within or near the €10k range. A higher budget in the UK does not create a standard access route for patients above 50. See the IVF with donor eggs over 50 guide for which countries remain realistic.
If anonymous donation is fine: a higher budget in Spain may widen clinic choice within a well-established network, but does not change the anonymous-only legal system. Czech Republic, North Cyprus, and South Africa remain competitive at lower cost if their constraints fit your situation.
If regulatory transparency matters most: the UK (HFEA-regulated) and Denmark are the strongest fits in terms of oversight. The UK is the most expensive destination in the covered set; Denmark is the most age-restricted.
If timing matters: the UK can be slower in practice, depending on donor availability and clinic capacity. Spain may offer faster access in some cases, though this varies by clinic and matching requirements.

How the covered countries compare once budget is not the main filter

All eight covered countries are shown below, sorted by cost range. Age limits across the set range from 46 to around 58.¹

Identifiable donation is the priority: focus on the UK and Portugal
Age access above 50 matters most: look at Greece and North Cyprus
Under 46, want to choose your donor system: Denmark is the only option with a genuine choice
Anonymous donation is fine: Spain has the most established network

Country	Donor type	Age limit	Single women	Est. cost range²
United Kingdom	Identifiable	Around 50	Yes	€9,500–€13,500
Portugal	Identifiable	Around 50	Yes	€6,000–€9,000
Denmark	Choice	46	Yes	€5,500–€9,000
South Africa	Anonymous	Around 50	Yes	€5,500–€8,500
Spain	Anonymous	Around 50	Yes	€5,500–€8,000
Greece	Mixed³	54	Yes	€5,500–€8,000
North Cyprus	Anonymous	Around 58	Yes	€5,000–€7,000
Czech Republic	Anonymous	49	No	€4,900–€6,500

When a higher budget is worth it

Situations where spending more buys a real advantage

Identifiable donation in the UK The UK requires identifiable donors by law, meaning children can access the donor's identity at 18. Treatment is HFEA-regulated, with the highest regulatory oversight of any covered destination. Cost reflects that: €9,500 to €13,500 for a base cycle. Timing can be slower in practice, depending on clinic and donor availability.

Donor-type flexibility in Denmark Denmark offers a choice between anonymous and identifiable donors. That flexibility matters if you haven't settled that decision yet, or want both options available. The trade-off is strict: Denmark closes at 46 with no exceptions.

Identifiable donation at a lower cost, through Portugal Portugal uses the same legal donor-type system as the UK (identifiable donation by law) at a materially lower base cost (€6,000–€9,000 vs €9,500–€13,500). The clinic network is smaller and donor availability may vary. If identifiable donation is the priority and budget is a consideration, Portugal is worth comparing directly against the UK before deciding.

Spain, if anonymous donation fits your situation Spain's established clinic network and large donor pool mean access is often relatively fast for frozen donor cycles, though timing varies by clinic and donor requirements. A higher budget may widen clinic choice, but Spanish law requires donor anonymity throughout. This option is only relevant if you are comfortable with that system.

What a higher budget doesn't solve

Structural constraints that budget doesn't change

Donor type is a legal system, not a financial one Spain, Czech Republic, North Cyprus, and South Africa are anonymous-only by law. Paying more does not add identifiable donors in those countries. If identifiable donation is essential, the relevant options are Portugal, the UK, and Denmark (before 46 only).

Age limits are fixed by law and clinic policy Denmark closes at 46 regardless of what you spend. The UK does not offer a standard access route above around 50. A higher budget does not extend those limits. If you are over 50, Greece and North Cyprus are the countries to compare, and both typically fall within or near the €10k range.

Single-women access is structural Czech Republic excludes single women regardless of budget. All other covered countries accept single women. This is a policy question, not a pricing one.

Regulatory jurisdiction doesn't change with what you spend North Cyprus operates outside the EU regulatory framework. A higher budget does not change that context. For users where EU regulation is a deciding factor, North Cyprus remains a different kind of trade-off regardless of cost.

What shifts when budget stops being the constraint

You can now consider

But you still face

UK: HFEA regulation and a well-established identifiable donor system

The most expensive option in the covered set, and often slower in practice

Denmark: genuine choice between anonymous and identifiable donation

Closes at 46, no exceptions. If you are already over 46, Denmark is not on the shortlist

Portugal: identifiable donation at a lower base cost than the UK

Smaller clinic network; donor availability and timing can vary

Spain: broad anonymous-donation options at established clinics

Anonymous only, regardless of budget. No identifiable option exists in the Spanish system

Greece: age access to 54 at a still-manageable cost

Primarily anonymous in practice; permit required from the national health authority above 50

The key question once budget is no longer the constraint

Once budget stops being the main filter, start with the harder questions. Do you need anonymous or identifiable donation? Are you approaching an age cutoff? Does regulatory context matter to you? The better route is usually decided there, not by price alone.

Where to go next

If donor type is the deciding question, anonymous vs identifiable donation explains the legal differences and which countries fall on each side.
If you want to compare all eight countries across donor type, age, access, and cost, compare all 8 countries side by side.
If you want to understand what a clinic quote typically includes and what gets added later, the hidden costs guide breaks down what is usually separate from the base price.

Common questions

Only in countries where identifiable donation is legally available. Portugal and the UK are identifiable-only by law. Denmark offers a choice between anonymous and identifiable. Spain, Czech Republic, North Cyprus, and South Africa are anonymous-only by law. A higher budget does not add identifiable donors to those systems.

It depends on what you are actually buying. The UK offers HFEA regulation, identifiable donation by law, and a familiar treatment environment. The cost is real: €9,500 to €13,500 for a base cycle, and timing can be slower depending on clinic and donor availability. If identifiable donation and regulatory transparency are non-negotiable, the UK may make sense. If the priority is identifiable donation at a lower cost, Portugal is worth comparing first.

Prices vary because of differences in labour costs, donor compensation rules, donor availability, the regulatory framework, and what the clinic package actually includes. A higher quote may reflect broader package scope, add-ons like PGT-A or expanded screening, or simply a different cycle structure. That does not automatically mean better treatment. Countries like the UK and Denmark tend to be more expensive because of stricter donor rules and smaller donor pools, not because clinical standards are higher. The UK is the clearest outlier: its cost reflects HFEA regulation, identifiable donation, and the domestic market structure. Other destinations can offer lower prices for structural reasons that do not automatically mean lower standards.

If identifiable donation is the priority, yes. Portugal uses the same donor-type system as the UK (identifiable by law) at a materially lower base cost (€6,000–€9,000 vs €9,500–€13,500). The clinic network is smaller and donor availability may vary, but it is worth comparing directly against the UK before deciding. The main reason to choose the UK over Portugal is regulatory transparency and the HFEA framework, not donor type alone.

No. Age access is determined by law and clinical policy, not by what you spend. Above 50, Greece (to 54) and North Cyprus (to around 58) are the two countries with structured access. Both typically sit at or below the €10k range at base price. A higher budget in the UK does not create a standard access route for patients above 50.

Age is measured at embryo transfer. Allow time for donor matching and cycle preparation.
These are editorial estimates for the base clinic package for a frozen donor egg cycle. They are not guaranteed prices and do not include recipient medication, travel, accommodation, optional add-ons, or extra procedures.
Greek law allows anonymous and identity-release donors, but most clinics still primarily operate with anonymous donor pools.

When budget stops being the main filter

What a higher budget actually changes

How your situation shapes what matters next

How the covered countries compare once budget is not the main filter

When a higher budget is worth it

What a higher budget doesn't solve

What shifts when budget stops being the constraint

Common questions

Start here

By age

By eligibility

By donor type

By budget

Compare and decide